Test for Alzheimer’s disease directly measures synaptic loss
Researchers have tested a new method for directly measuring synaptic loss in individuals with Alzheimer’s disease. The method, which uses PET imaging technology to scan for a specific protein in the brain linked to synapses, has the potential to accelerate research for new Alzheimer’s treatments, the researchers said.
Original source: https://www.sciencedaily.com/releases/2018/07/180716151600.htm
